Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Urology
Volume 2017, Article ID 7903242, 3 pages
https://doi.org/10.1155/2017/7903242
Case Report

Rare Case of a Well-Differentiated Paratesticular Sarcoma of the Spermatic Cord in a 60-Year-Old Patient

1Department of Radiation Therapy, Salah Azaiez Institute, Tunis, Tunisia
2Department of Urology, Charles Nicole Hospital, Tunis, Tunisia

Correspondence should be addressed to Marwen Benna; moc.liamg@anneb.newram

Received 17 September 2016; Accepted 29 December 2016; Published 2 March 2017

Academic Editor: Beatrice Detti

Copyright © 2017 Marwen Benna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Introduction. Liposarcomas are tumors that occur mostly in the retroperitoneum. Of all liposarcomas only 3 to 7% are found in the paratesticular region. The spermatic cord is the main site of origin in these cases. The patients ages range from 50 to 60 years. This malignant disease can result in a loss of fertility aside from life-threatening sequelae. Case. We present a case of a liposarcoma of the paratesticular region. A 60-year-old man was referred with a painless mass in the scrotum and the right inguinal region. The patient underwent surgery and the mass was removed along with the right testis, the spermatic cord, and the soft tissues to the internal inguinal ring. Histopathological examination found a well-differentiated liposarcoma of  mm. The surgical margins were negative. The adjuvant treatment consisted in radiation therapy of the right inguinoscrotal area to the dose of 54 Gray, 2 Gy per session, 5 times a week. Conclusion. Paratesticular liposarcomas are rare tumors. Surgery with large margin resections was the main treatment in all reported cases. The adjuvant treatment is still unclear especially when the surgical margins are negative. The main factor that indicated this adjuvant treatment was the size of the tumor and the histologic subtype.